It is a pharma private limited company based in Nasik, Maharashtra, India, established in 2003.
2003 | Nasik, Maharashtra, India | ActiveMax Formulations Private Limited, a active private limited company, was established on 03 January 2003 in Nasik, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2003PTC138530. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.60 M.
It upholds a active non-compliant status. Its leadership includes Vaibhav Vijay Patil (Director), Dhananjay Rajendra Kale (Director), Kiran Sudhakar Patil (Director). It holds ₹2.00 Cr open charges and ₹8.75 M settled loans. Its latest AGM occurred on 30 September 2006, with the balance sheet filed on 31 March 2006. It is based at B-24/25 Nice Areasatpur Industrial Area Nasik, Nasik, Maharashtra, 422007.
U24230MH2003PTC138530
138530
03 January 2003
₹3.00 M
₹2.60 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Max Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhav Vijay Patil | Director | 03 Jan 2003 | Current |
| Dhananjay Rajendra Kale | Director | 22 Aug 2006 | Current |
| Kiran Sudhakar Patil | Director | 02 Apr 2008 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Max Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Max Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹8,745,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Dec 2007 | The Hongkong And Shanghai Banking Corporation | ₹2.00 Cr | Open |
| 22 May 2003 | Bank Of India | ₹8.75 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Max Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Max Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Max Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 22 May 2003 via Charge ID 90148284 with Bank Of India was fully satisfied on 09 Jan 2009. was recorded as a recent event.
The activity Kiran Sudhakar Patil was appointed as a Director was appointed as a Director on 02 Apr 2008 & has been associated with this company since 17 years 8 months . was completed.
Progress on A charge with The Hongkong And Shanghai Banking Corporation amounted to Rs. 20.00 M with Charge ID 10084715 was registered on 06 Dec 2007. was documented.
Progress on Max Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2006 as per latest MCA records. was documented.
The activity Dhananjay Rajendra Kale was appointed as a Director was appointed as a Director on 22 Aug 2006 & has been associated with this company since 19 years 4 months . was completed.
Progress on Max Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2006 with Roc Mumbai. was documented.
The CIN of Max Formulations Private Limited is U24230MH2003PTC138530.
Max Formulations Private Limited is headquartered at B-24/25 Nice Areasatpur Industrial Area Nasik, Nasik, Maharashtra, 422007.
Max Formulations Private Limited was incorporated on 03 January 2003.
The current directors of Max Formulations Private Limited are
The primary industry of Max Formulations Private Limited is Pharma.
Max Formulations Private Limited is unlisted.
The authorized capital of Max Formulations Private Limited is ₹3.00 M, and the paid-up capital is ₹2.60 M.
The compliance status of Max Formulations Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX